SE427111B - Sett att framstella pilokarpiniumsalter - Google Patents
Sett att framstella pilokarpiniumsalterInfo
- Publication number
- SE427111B SE427111B SE7610218A SE7610218A SE427111B SE 427111 B SE427111 B SE 427111B SE 7610218 A SE7610218 A SE 7610218A SE 7610218 A SE7610218 A SE 7610218A SE 427111 B SE427111 B SE 427111B
- Authority
- SE
- Sweden
- Prior art keywords
- pilocarpinum
- salts
- make
- pilocarpinum salts
- make pilocarpinum
- Prior art date
Links
- QCHFTSOMWOSFHM-WPRPVWTQSA-N (+)-Pilocarpine Chemical class C1OC(=O)[C@@H](CC)[C@H]1CC1=CN=CN1C QCHFTSOMWOSFHM-WPRPVWTQSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US05/620,623 US4045558A (en) | 1975-10-08 | 1975-10-08 | Pilocarpine salts |
Publications (2)
Publication Number | Publication Date |
---|---|
SE7610218L SE7610218L (sv) | 1977-04-09 |
SE427111B true SE427111B (sv) | 1983-03-07 |
Family
ID=24486667
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE7610218A SE427111B (sv) | 1975-10-08 | 1976-09-15 | Sett att framstella pilokarpiniumsalter |
Country Status (9)
Country | Link |
---|---|
US (1) | US4045558A (sv) |
JP (1) | JPS5247911A (sv) |
CH (1) | CH623819A5 (sv) |
DE (1) | DE2644156A1 (sv) |
DK (1) | DK415676A (sv) |
FR (1) | FR2326922A1 (sv) |
GB (1) | GB1510939A (sv) |
NL (1) | NL7610208A (sv) |
SE (1) | SE427111B (sv) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL69593A (en) * | 1982-09-17 | 1988-09-30 | Bundegaard Hans | Pilocarpine prodrugs,their preparation and pharmaceutical compositions containing them |
US5166331A (en) * | 1983-10-10 | 1992-11-24 | Fidia, S.P.A. | Hyaluronics acid fractions, methods for the preparation thereof, and pharmaceutical compositions containing same |
US5990096A (en) * | 1990-09-18 | 1999-11-23 | Hyal Pharmaceutical Corporation | Formulations containing hyaluronic acid |
CA2061703C (en) * | 1992-02-20 | 2002-07-02 | Rudolf E. Falk | Formulations containing hyaluronic acid |
US5910489A (en) * | 1990-09-18 | 1999-06-08 | Hyal Pharmaceutical Corporation | Topical composition containing hyaluronic acid and NSAIDS |
US5824658A (en) * | 1990-09-18 | 1998-10-20 | Hyal Pharmaceutical Corporation | Topical composition containing hyaluronic acid and NSAIDS |
US6103704A (en) * | 1991-07-03 | 2000-08-15 | Hyal Pharmaceutical Corporation | Therapeutic methods using hyaluronic acid |
US5977088A (en) * | 1991-07-03 | 1999-11-02 | Hyal Pharmaceutical Corporation | Formulations containing hyaluronic acid |
US5792753A (en) * | 1991-07-03 | 1998-08-11 | Hyal Pharmaceutical Corporation | Compositions comprising hyaluronic acid and prostaglandin-synthesis-inhibiting drugs |
US6218373B1 (en) | 1992-02-20 | 2001-04-17 | Hyal Pharmaceutical Corporation | Formulations containing hyaluronic acid |
US5767106A (en) * | 1992-02-21 | 1998-06-16 | Hyal Pharmaceutical Corporation | Treatment of disease and conditions associated with macrophage infiltration |
US5684155A (en) * | 1993-07-06 | 1997-11-04 | Polis A.G. | Process for the extraction and purification of alkaloids |
JP4605726B2 (ja) * | 1997-09-02 | 2011-01-05 | 日本曹達株式会社 | フェノール誘導体を成分化合物とする分子化合物 |
US20060029665A1 (en) * | 2004-08-03 | 2006-02-09 | Transoral Pharmaceuticals, Inc. | Pilocarpine compositions and methods of use thereof |
CA2617040A1 (en) * | 2005-07-29 | 2007-02-01 | Santen Pharmaceutical Co., Ltd. | Non-invasive drug delivery system targeting posterior eye tissue using solid composition |
KR102442758B1 (ko) * | 2016-10-04 | 2022-09-14 | 셀릭스 바이오 프라이빗 리미티드 | 구강건조증(xerostomia)의 치료를 위한 조성물 및 방법 |
CN118679159A (zh) * | 2022-01-29 | 2024-09-20 | 南京济群医药科技股份有限公司 | 一种m-胆碱受体激动剂化合物及其制备方法和用途 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3450814A (en) * | 1964-07-15 | 1969-06-17 | Chemway Corp | Ophthalmic compositions containing alginic acid salts of pilocarpine,atropine and physostigmine |
IL25251A (en) * | 1965-07-20 | 1969-11-12 | Merck & Co Inc | Aqueous mixtures for ophthalmology based on hydroxyethylcellulose and a method for their preparation |
US3845201A (en) * | 1972-04-24 | 1974-10-29 | S Loucas | Solid state ophthalmic medication delivery method |
US3875300A (en) * | 1972-12-18 | 1975-04-01 | Ortho Pharma Corp | Composition for sustained release of a medicament and method of using same |
-
1975
- 1975-10-08 US US05/620,623 patent/US4045558A/en not_active Expired - Lifetime
-
1976
- 1976-09-14 NL NL7610208A patent/NL7610208A/xx not_active Application Discontinuation
- 1976-09-15 DK DK415676A patent/DK415676A/da not_active Application Discontinuation
- 1976-09-15 SE SE7610218A patent/SE427111B/sv not_active IP Right Cessation
- 1976-09-29 GB GB40447/76A patent/GB1510939A/en not_active Expired
- 1976-09-29 FR FR7629262A patent/FR2326922A1/fr active Granted
- 1976-09-30 CH CH1239276A patent/CH623819A5/de not_active IP Right Cessation
- 1976-09-30 DE DE19762644156 patent/DE2644156A1/de not_active Ceased
- 1976-10-01 JP JP51117347A patent/JPS5247911A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
FR2326922A1 (fr) | 1977-05-06 |
JPS5247911A (en) | 1977-04-16 |
NL7610208A (nl) | 1977-04-13 |
CH623819A5 (sv) | 1981-06-30 |
DK415676A (da) | 1977-04-09 |
SE7610218L (sv) | 1977-04-09 |
FR2326922B1 (sv) | 1979-07-20 |
GB1510939A (en) | 1978-05-17 |
US4045558A (en) | 1977-08-30 |
DE2644156A1 (de) | 1977-04-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE433222B (sv) | Sett att framstella modifierad polysackarid | |
SE432247B (sv) | Sett att framstella dihydro-cyklosporin c | |
SE7606280L (sv) | Sett att framstella etrar | |
SE440779B (sv) | Sett att framstella androstan-17-on-derivat | |
SE433492B (sv) | Sett att framstella fenylettiksyraderivat | |
SE412818B (sv) | Sett att framstella en halvdedarminnesanordning | |
SE430887B (sv) | Sett att framstella vissa substituerade fenylguanidiner | |
SE441042B (sv) | Sett att pavisa rheumatoida faktorer | |
SE427111B (sv) | Sett att framstella pilokarpiniumsalter | |
SE420728B (sv) | Sett att framstella piperazinyliminorifamyciner | |
SE425736B (sv) | Sett att framstella kromanon-(4) | |
SE432256B (sv) | Sett att framstella cellulosaalkyletrar | |
SE430687B (sv) | Sett att framstella hexanitrostilben | |
SE7602729L (sv) | Sett att framstella nya indolylalkylpiperidiner | |
SE420732B (sv) | Sett att framstella 4-gonen-3-oner | |
SE424991B (sv) | Sett att framstella nya 5-fenyl-oxazolidinoner | |
SE430156B (sv) | Sett att framstella 2-subst-1-(omega-aminoalkoxi)-bensener | |
SE434397B (sv) | Sett att framstella bens-acyl-bensimidazol-2-derivat | |
SE427655B (sv) | Sett att framstella abietamidderivat | |
SE7607171L (sv) | Sett att framstella indolokinoliziner | |
SE7608939L (sv) | Sett att framstella pyrrolinderivat | |
SE420690B (sv) | Sett att kontinuerligt framstella vermeisolerande ledningsror | |
SE433213B (sv) | Sett att framstella 2 -fenyl-3-amino-benso/b/tiofenderivat | |
SE420731B (sv) | Sett att framstella 5-androsten-17-on-derivat | |
SE7601564L (sv) | Sett att framstella tabletter |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NUG | Patent has lapsed |
Ref document number: 7610218-5 Effective date: 19940410 Format of ref document f/p: F |